Florence Tubach

10PUBLICATIONS
44CO-AUTHORS
Predictive and prognostic markersInnate immunityCardiology (incl. cardiovascular diseases)Molecular targetsClinical chemistry (incl. diagnostics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 10, 2026
COVID-19 vaccination around immune checkpoint inhibitor start and survival in a nationwide cohort of patients with cancer.

|Mar 20, 2026
Recombinant vs Standard Influenza Vaccine in Adults With Severe Obesity: A Randomized Clinical Trial.

Paul Loubet, Sébastien Czernichow, Caroline Giboin

|Jan 15, 2026
Cardiovascular risk among Giant cells arteritis patients.

Alexis F Guedon, Olivier Espitia, Maxime Beydon

|Aug 30, 2025
Incidence and risk factors of immune checkpoint inhibitor myocardial and muscle toxicity: a French nationwide study.

Joe-Elie Salem, Aya Ajrouche, Antoine Rozes

|Jun 11, 2025
Association between hypoglycaemic drug de-intensification, mortality and hospital admission in older adults with type 2 diabetes: a cohort study emulating a target trial.

Antoine Christiaens, Alexis Cochard, Florence Tubach

|Nov 26, 2024
Prognostic factors for patients with cancer-associated dermatomyositis: a retrospective, multicentre cohort study of 73 patients.

Alexandre Teboul, Yves Allenbach, Florence Tubach

Pageof 2

Frequent Collaborators

5 joint publications

Joe-Elie Salem

3 joint publications

Baptiste Abbar

3 joint publications

Pierre-Yves Courand

3 joint publications

Jennifer Cautela